Zhongke Biotech (01237) issued an announcement. On April 15, 2024, in accordance with the terms of the share award plan...
According to Zhitong Finance App, Zhongke Biotech (01237) announced that on April 15, 2024, the company granted 3.9 million bonus shares involving new shares to employee participants (“grantor”) in accordance with the terms of the share award program (subject to acceptance by the grantor), accounting for about 4.23% of the total number of issued shares on the date of this announcement and about 4.06% of the total number of issued shares after the issuance and allocation of bonus shares was expanded.
The Board believes that granting grantees will motivate grantees and will allow the Group to attract, retain and motivate talents for their continued operation and development. Grantees are awarded in recognition of their continued support for the Group and their efforts will help the Group's future development. Furthermore, the Group grants incentives to grantees and will not generate any actual cash outflows.